tm logo
ERBITUX
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 04 Jul 2014

Last Applicant/ Owned by

450 East 29th Street

New York

NY

10016

Serial Number

76672082 filed on 01st Feb 2007

Registration Number

3342502 registered on 27th Nov 2007

in the Principal Register

Correspondent Address

Robert E. Lee, Jr.

Eli Lilly and Company

Lilly Corporate Center

Indianapolis IN 46285

Filing Basis

1. use application currently

Disclaimer

NO DATA

ERBITUX

The mark comprises the word ERBITUX and an antibody design. PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER Color is not claimed as a feature of the mark.

Classification Information


Class [005]
Pharmaceutical Products


PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER


First Use Date in General

19th Feb 2004

First Use Date in Commerce

19th Feb 2004

Mark Details


Serial Number

No 76672082

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

26.17.12 -

Chevrons and angles

Description of Design Search

The mark comprises the word ERBITUX and an antibody design.

Legal History


Show more

Status DateAction Taken
04th Jul 2014CANCELLED SEC. 8 (6-YR)
20th May 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
20th May 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03rd Jun 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Jun 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04th Feb 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
21st Mar 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
27th Nov 2007REGISTERED-PRINCIPAL REGISTER
11th Sep 2007PUBLISHED FOR OPPOSITION
22nd Aug 2007NOTICE OF PUBLICATION